Literature DB >> 25126392

Type 2 diabetes and cardiovascular disease: Have all risk factors the same strength?

Iciar Martín-Timón1, Cristina Sevillano-Collantes1, Amparo Segura-Galindo1, Francisco Javier Del Cañizo-Gómez1.   

Abstract

Diabetes mellitus is a chronic condition that occurs when the body cannot produce enough or effectively use of insulin. Compared with individuals without diabetes, patients with type 2 diabetes mellitus have a considerably higher risk of cardiovascular morbidity and mortality, and are disproportionately affected by cardiovascular disease. Most of this excess risk is it associated with an augmented prevalence of well-known risk factors such as hypertension, dyslipidaemia and obesity in these patients. However the improved cardiovascular disease in type 2 diabetes mellitus patients can not be attributed solely to the higher prevalence of traditional risk factors. Therefore other non-traditional risk factors may be important in people with type 2 diabetes mellitus. Cardiovascular disease is increased in type 2 diabetes mellitus subjects due to a complex combination of various traditional and non-traditional risk factors that have an important role to play in the beginning and the evolution of atherosclerosis over its long natural history from endothelial function to clinical events. Many of these risk factors could be common history for both diabetes mellitus and cardiovascular disease, reinforcing the postulate that both disorders come independently from "common soil". The objective of this review is to highlight the weight of traditional and non-traditional risk factors for cardiovascular disease in the setting of type 2 diabetes mellitus and discuss their position in the pathogenesis of the excess cardiovascular disease mortality and morbidity in these patients.

Entities:  

Keywords:  Blood pressure; Cardiovascular disease; Dyslipidaemia; Homocysteine; Inflammation; Insulin resistance; Microalbuminuria; Obesity; Postprandial Hyperglycaemia; Type 2 diabetes mellitus

Year:  2014        PMID: 25126392      PMCID: PMC4127581          DOI: 10.4239/wjd.v5.i4.444

Source DB:  PubMed          Journal:  World J Diabetes        ISSN: 1948-9358


  303 in total

Review 1.  Critical nodes in signalling pathways: insights into insulin action.

Authors:  Cullen M Taniguchi; Brice Emanuelli; C Ronald Kahn
Journal:  Nat Rev Mol Cell Biol       Date:  2006-02       Impact factor: 94.444

Review 2.  Role of oxidized low density lipoprotein in atherogenesis.

Authors:  J L Witztum; D Steinberg
Journal:  J Clin Invest       Date:  1991-12       Impact factor: 14.808

3.  Abnormal skeletal muscle capillary recruitment during exercise in patients with type 2 diabetes mellitus and microvascular complications.

Authors:  Lisa Womack; Dawn Peters; Eugene J Barrett; Sanjiv Kaul; Wendie Price; Jonathan R Lindner
Journal:  J Am Coll Cardiol       Date:  2009-06-09       Impact factor: 24.094

4.  Haptoglobin phenotype is an independent risk factor for cardiovascular disease in individuals with diabetes: The Strong Heart Study.

Authors:  Andrew P Levy; Irit Hochberg; Kathleen Jablonski; Helaine E Resnick; Elisa T Lee; Lyle Best; Barbara V Howard
Journal:  J Am Coll Cardiol       Date:  2002-12-04       Impact factor: 24.094

5.  [Side effects of caffeine].

Authors:  Wojciech Dworzański; Grzegorz Opielak; Franciszek Burdan
Journal:  Pol Merkur Lekarski       Date:  2009-11

6.  Common genetic variation in the promoter of the human apo CIII gene abolishes regulation by insulin and may contribute to hypertriglyceridemia.

Authors:  W W Li; M M Dammerman; J D Smith; S Metzger; J L Breslow; T Leff
Journal:  J Clin Invest       Date:  1995-12       Impact factor: 14.808

7.  Relation of microalbuminuria and coronary artery disease in patients with and without diabetes mellitus.

Authors:  Rishi Sukhija; Wilbert S Aronow; Priyanka Kakar; Luis Garza; Rajesh Sachdeva; Anjan Sinha; Jawahar L Mehta
Journal:  Am J Cardiol       Date:  2006-06-06       Impact factor: 2.778

8.  Transcriptional regulation of the apoC-III gene by insulin in diabetic mice: correlation with changes in plasma triglyceride levels.

Authors:  M Chen; J L Breslow; W Li; T Leff
Journal:  J Lipid Res       Date:  1994-11       Impact factor: 5.922

9.  C-reactive protein and 5-year survival in type 2 diabetes: the Casale Monferrato Study.

Authors:  Graziella Bruno; Paolo Fornengo; Giulia Novelli; Francesco Panero; Massimo Perotto; Olivia Segre; Chiara Zucco; PierCarlo Deambrogio; Giuseppe Bargero; Paolo Cavallo Perin
Journal:  Diabetes       Date:  2008-12-15       Impact factor: 9.461

10.  Genetic analysis of haptoglobin polymorphisms with cardiovascular disease and type 2 diabetes in the Diabetes Heart Study.

Authors:  Jeremy N Adams; Amanda J Cox; Barry I Freedman; Carl D Langefeld; J Jeffrey Carr; Donald W Bowden
Journal:  Cardiovasc Diabetol       Date:  2013-02-11       Impact factor: 9.951

View more
  177 in total

1.  Sinonasal Mucormycosis: A to Z.

Authors:  V P Singh; Chetan Bansal; Madhuri Kaintura
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2018-05-04

2.  Ameliorative potential of conditioning on ischemia-reperfusion injury in diabetes.

Authors:  Ashish K Rehni; Kunjan R Dave
Journal:  Cond Med       Date:  2018-04-20

3.  Correlation between hemoglobin A1c and serum lipid profile in Afghani patients with type 2 diabetes: hemoglobin A1c prognosticates dyslipidemia.

Authors:  Arshad Hussain; Iftikhar Ali; Muhammad Ijaz; Afaq Rahim
Journal:  Ther Adv Endocrinol Metab       Date:  2017-03-20       Impact factor: 3.565

4.  A20 prevents obesity-induced development of cardiac dysfunction.

Authors:  Wenjing Xu; Cheng Wang; Minglu Liang; Long Chen; Qin Fu; Fengxiao Zhang; Yan Wang; Dan Huang; Kai Huang
Journal:  J Mol Med (Berl)       Date:  2017-11-16       Impact factor: 4.599

5.  Up-Regulation of CREG Expression by the Transcription Factor GATA1 Inhibits High Glucose- and High Palmitate-Induced Apoptosis in Human Umbilical Vein Endothelial Cells.

Authors:  Yanxia Liu; Xiaoxiang Tian; Yang Li; Dan Liu; Meili Liu; Xiaolin Zhang; Quanyu Zhang; Chenghui Yan; Yaling Han
Journal:  PLoS One       Date:  2016-05-03       Impact factor: 3.240

6.  Multiscale and morphological analysis of microvascular patterns depicted in contrast-enhanced ultrasound images.

Authors:  Ipek Oezdemir; Jun Peng; Debabrata Ghosh; Shashank Sirsi; Chieko Mineo; Philip W Shaul; Kenneth Hoyt
Journal:  J Med Imaging (Bellingham)       Date:  2020-06-02

7.  Relationship of adverse events to quality of anticoagulation control in atrial fibrillation patients with diabetes: real-world data from the FANTASIIA Registry.

Authors:  Amaya García-Fernández; María Asunción Esteve-Pastor; Inmaculada Roldán-Rabadán; Javier Muñiz; Martín Ruiz Ortiz; Ángel Cequier; Vicente Bertomeu-Martínez; Lina Badimón; Déborah Otero; Manuel Anguita; Gregory Y H Lip; Francisco Marín
Journal:  Ann Med       Date:  2020-06-17       Impact factor: 4.709

8.  Tissue factor levels in type 2 diabetes mellitus.

Authors:  Prashilla Soma; Albe C Swanepoel; Janette Bester; Etheresia Pretorius
Journal:  Inflamm Res       Date:  2017-02-28       Impact factor: 4.575

Review 9.  Clinical assessment of endothelial function in patients with chronic obstructive pulmonary disease: a systematic review with meta-analysis.

Authors:  Pasquale Ambrosino; Roberta Lupoli; Salvatore Iervolino; Alberto De Felice; Nicola Pappone; Antonio Storino; Matteo Nicola Dario Di Minno
Journal:  Intern Emerg Med       Date:  2017-06-07       Impact factor: 3.397

10.  Cardiovascular Disease Incidence and Risk Factor Patterns among Omanis with Type 2 Diabetes: A Retrospective Cohort Study.

Authors:  Abdul Hakeem Al Rawahi; Patricia Lee; Zaher A M Al Anqoudi; Ahmed Al Busaidi; Muna Al Rabaani; Faisal Al Mahrouqi; Ahmed M Al Busaidi
Journal:  Oman Med J       Date:  2017-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.